Literature DB >> 7971715

Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.

H Okada1, Y Doken, Y Ogawa, H Toguchi.   

Abstract

To obtain a three-month release injection of leuprorelin acetate, microspheres were prepared with copoly(DL-lactic/glycolic acid) or poly(DL-lactic acid) (PLA) using an in-water drying method, and drug release was evaluated. The content of water-soluble oligomers in the polymers was found to strongly affect the initial burst, and reducing the content to less than 0.1% was necessary to keep the first-day release below 10%. Drug loading of more than 15% also increased the initial drug release; the acceptable maximum loading was 12%. Elevation of the glass transition temperature of the microspheres was observed with an increase in drug loading. This suggests formation of a rigid structure, possibly with arrangement of the polymer around the drug cores like in a micelle. This structure provides a hydrophobic barrier against diffusion of the hydrophilic peptide, resulting in high trapping efficiency and long-term sustained release dependent on polymer erosion. The microspheres prepared with PLA having a m.w. of 12,000 to 18,000 provided linear sustained release and persistent serum levels of the drug in rats for over 3 months.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7971715     DOI: 10.1023/a:1018936815654

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate.

Authors:  H Okada; T Heya; Y Ogawa; H Toguchi; T Shimamoto
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

2.  Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group.

Authors:  R Sharifi; M Soloway
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

3.  Tissue response to biodegradable injectable microcapsules.

Authors:  G E Visscher; M A Robison; G J Argentieri
Journal:  J Biomater Appl       Date:  1987-07       Impact factor: 2.646

4.  Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals.

Authors:  Y Ogawa; H Okada; T Heya; T Shimamoto
Journal:  J Pharm Pharmacol       Date:  1989-07       Impact factor: 3.765

5.  Long-acting delivery systems for narcotic antagonists. 1.

Authors:  J H Woodland; S Yolles; D A Blake; M Helrich; F J Meyer
Journal:  J Med Chem       Date:  1973-08       Impact factor: 7.446

6.  A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid.

Authors:  Y Ogawa; M Yamamoto; H Okada; T Yashiki; T Shimamoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-03       Impact factor: 1.645

7.  In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers.

Authors:  Y Ogawa; H Okada; M Yamamoto; T Shimamoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-07       Impact factor: 1.645

8.  One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.

Authors:  H Okada; T Heya; Y Ogawa; T Shimamoto
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

9.  Preparation and in vitro degradation properties of polylactide microcapsules.

Authors:  K Makino; M Arakawa; T Kondo
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-03       Impact factor: 1.645

10.  A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.

Authors:  A J Friedman; D Harrison-Atlas; R L Barbieri; B Benacerraf; R Gleason; I Schiff
Journal:  Fertil Steril       Date:  1989-02       Impact factor: 7.329

View more
  29 in total

1.  pH and osmotic pressure inside biodegradable microspheres during erosion.

Authors:  A Brunner; K Mäder; A Göpferich
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  In vitro characterization and in vivo testosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres.

Authors:  Byung Ho Woo; Kyu-Heum Na; Bhas A Dani; Ge Jiang; B C Thanoo; Patrick P DeLuca
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

Review 3.  Clinical pharmacokinetics of depot leuprorelin.

Authors:  Piero Periti; Teresita Mazzei; Enrico Mini
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Freeze-drying of microparticulates in a vibro-separator.

Authors:  K H Na; B H Woo; Y W Jo; A M Hazrati; P P DeLuca
Journal:  AAPS PharmSciTech       Date:  2001-06-30       Impact factor: 3.246

Review 5.  Advances in Biomaterials for Drug Delivery.

Authors:  Owen S Fenton; Katy N Olafson; Padmini S Pillai; Michael J Mitchell; Robert Langer
Journal:  Adv Mater       Date:  2018-05-07       Impact factor: 30.849

6.  A semi-mechanistic integrated pharmacokinetic/pharmacodynamic model of the testosterone effects of the gonadotropin-releasing hormone agonist leuprolide in prostate cancer patients.

Authors:  Chay Ngee Lim; Ahmed Hamed Salem
Journal:  Clin Pharmacokinet       Date:  2015-09       Impact factor: 6.447

7.  Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres.

Authors:  Emmamuel O Akala; Pornruedee Wiriyacoonkasem; Gaofeng Pan
Journal:  Drug Dev Ind Pharm       Date:  2011-03-30       Impact factor: 3.225

8.  High bioavailabilty of alpha-tocopherol loaded into poly (DL-lactic-co-glycolic acid) microspheres in apolipoprotein B knockout mice.

Authors:  Koichi Yokogawa; Yuichiro Shima; Tomoka Hashimoto; Makoto Hiyajyo; Kaori Kadoyama; Junko Ishizaki; Masaaki Nomura; Ken-ichi Miyamoto
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 9.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

10.  Preparation of intravenous stealthy acyclovir nanoparticles with increased mean residence time.

Authors:  Amany O Kamel; Gehanne A S Awad; Ahmed S Geneidi; Nahed D Mortada
Journal:  AAPS PharmSciTech       Date:  2009-12-01       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.